Neurim Pharmaceuticals (“Neurim”) announces that the Committee for Medicinal Products for Human Use (CHMP) of the …
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced …
